Inventor · disambiguated record
Esther Priel
Also filed as: PRIEL ESTHER
10 granted patents·55 citations·filing 1990–2018
88Inventor score
Files withBEN-GURION UNIV OF THE NEGEV RES AND DEV AUTHORITY3BEN GURION UNIV OF THE NEGEV RESEARCH AND DEVELOPMENT AUTHORITY2US HEALTH2GAZIT AVIV1NEUROMAGEN PHARMA LTD1
Top patents by PatentIndex Score
10 records- 0182US8609736B2Telomerase activating compounds and methods of use thereofGAZIT AVIV·Filed 2008·Granted Dec 17, 2013·7 cites·13 claims
- 0282US8604245B2Tri-aryl compounds and compositions comprising the samePRIEL ESTHER·Filed 2008·Granted Dec 10, 2013·7 cites·10 claims
- 0379US10214481B2Telomerase activating compounds and methods of use thereofBEN GURION UNIV OF THE NEGEV RESEARCH AND DEVELOPMENT AUTHORITY·Filed 2017·Granted Feb 26, 2019·2 cites·9 claims
- 0477US9663448B2Tri-aryl compounds and compositions comprising the sameBEN-GURION UNIV OF THE NEGEV RES AND DEV AUTHORITY·Filed 2013·Granted May 30, 2017·2 cites·4 claims
- 0575US11857516B2Telomerase activating compounds for use in fertility and related applicationsNEUROMAGEN PHARMA LTD·Filed 2018·Granted Jan 2, 2024·1 cites·12 claims
- 0675US9670139B2Telomerase activating compounds and methods of use thereofBEN-GURION UNIV OF THE NEGEV RES AND DEV AUTHORITY·Filed 2013·Granted Jun 6, 2017·2 cites·5 claims
- 0775US9670138B2Telomerase activating compounds and methods of use thereofBEN-GURION UNIV OF THE NEGEV RES AND DEV AUTHORITY·Filed 2013·Granted Jun 6, 2017·2 cites·18 claims
- 0856US5622959AMethod of treating retroviral infections in mammalsUS HEALTH·Filed 1995·Granted Apr 22, 1997·16 cites·9 claims
- 0953US5422344AMethod of treating retroviral infections in mammalsUS HEALTH·Filed 1990·Granted Jun 6, 1995·16 cites·8 claims
- 1051US10111880B2Compounds for the treatment of diabetes and disease complications arising from sameBEN GURION UNIV OF THE NEGEV RESEARCH AND DEVELOPMENT AUTHORITY·Filed 2014·Granted Oct 30, 2018·0 cites·22 claims
Join the waitlist — get patent alerts
Get an alert when Esther Priel files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →